Tag Archives: PTLA

Portola Pharma (PTLA) Gets a Buy Rating from Citigroup

Citigroup analyst Yigal Nochomovitz maintained a Buy rating on Portola Pharma (PTLA – Research Report) today and set a price target of $44.00. The company’s shares closed last Monday at $27.03. According to TipRanks.com, Nochomovitz is a 4-star analyst with

William Blair Keeps a Buy Rating on Portola Pharma (PTLA)

William Blair analyst Matt Phipps reiterated a Buy rating on Portola Pharma (PTLA – Research Report) yesterday. The company’s shares opened today at $30.94. Phipps wrote: “We are encouraged by the continued growth of Andexxa, particularly with 74% of sales

Analysts Are Bullish on These Healthcare Stocks: Portola Pharma (PTLA), Sarepta Therapeutics (SRPT)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Portola Pharma (PTLA – Research Report) and Sarepta Therapeutics (SRPT – Research Report) with bullish sentiments. Portola Pharma (PTLA) Cowen & Co.

Portola Pharma (PTLA) Gets a Buy Rating from Oppenheimer

Oppenheimer analyst Jay Olson maintained a Buy rating on Portola Pharma (PTLA – Research Report) today and set a price target of $42. The company’s shares opened today at $32.06. Olson noted: “PTLA reported 1Q results roughly in line with

Analysts Offer Insights on Healthcare Companies: Portola Pharma (NASDAQ: PTLA) and Rocket Pharmaceuticals Inc (NASDAQ: RCKT)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Portola Pharma (PTLA – Research Report) and Rocket Pharmaceuticals Inc (RCKT – Research Report) with bullish sentiments. Portola Pharma (PTLA) Cowen &

Oppenheimer Keeps Their Buy Rating on Portola Pharma (PTLA)

Oppenheimer analyst Jay Olson maintained a Buy rating on Portola Pharma (PTLA – Research Report) today and set a price target of $42. The company’s shares opened today at $35.51. Olson said: “We examine several frequently asked questions in anticipation